Catalyst Wire Dossier Catalyst Wire Dossier

NECTAR-HF neural stimulation therapy

· Boston Scientific Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NECTAR-HF neural stimulation therapy, covering 2020-01-06 to 2020-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF) [NA]

See pricing